IMSTAR is a pioneer in the field of cell analysis for Life Sciences research and assisted In Vitro Diagnostic (IVD), providing innovative concepts in digital image cytometry and quantitative analysis through its proprietary Pathfinder™ technology.
The Company services clients in the fields of digital cyto-histopathology, cytogenetic and environmental mutagenesis and genetic toxicity, applied to a large range of tests for preclinical research, tumor biomarkers validation in assisted IVD, bio-monitoring and compounds screening, amongst others.

International Comet Assay Workshop (ICAW 2015)

Antwerp, Belgium, September 5th, 2015 – This symposium deals with practical and theoretical aspects of the Comet Assay, aimed at both experienced and new users of this popular technique. As part of the week long manifestation, IMSTAR provided a Comet Assays Hands-On Training session, demonstrating the accessibility and accuracy of their proprietary Pathfinder™ ScreenTox™ AutoComet fully automated scoring system.
“For the past 20 years, we have worked with leaders in the field of in vitro/in vivo genotoxicity testing and DNA damage assessment, aiming to advance the state of the art of automated comet assay analysis”, said Françoise Soussaline, IMSTAR CEO and CSO. The use of IMSTAR’s PathfinderTM fully-automated system allows not only the scoring of several-fold higher number of cells, as demonstrated in recent studies, but an improved accuracy and robustness for the test. An increased sensitivity of in vitro comet assay could be particularly important for biomonitoring studies where small differences in DNA damage levels could be relevant”.

Read more: http://www.imstarsa.com/wp-content/uploads/2015/09/Mutation-Research-749-2012-70%E2%80%93-75_Sharma-et-al.pdf

First International Symposium on the Impact of Occupational Exposures on DNA Stability and Human Cancer Risks

Graz, Austria, September 12th, 2015 – Millions of humans are currently exposed to chemicals and other factors which affect the stability of the genetic material and/or cause cancer and other long term toxic effects. To protect this part of the population, strong efforts have been made to monitor and reduce the risks of these harmful factors; nevertheless, biomonitoring represents still a tremendous challenge in terms of expertise, method and cost.
Françoise Soussaline, speaker in this symposium, presented a methodological approach in cytogenetic quantitative analysis and DNA damage evaluation for human biomonitoring using automated high-throughput high-content Image Cytometry, with the aim to assess the impact of nutrition, chemicals and radiation on genomic stability and other health related processes.

For more information, please contact:
IMSTAR S.A.
93 boulevard Arago
Paris 75014, France
Tel: +33 (0)1 42 34 93 70
Fax: +33 (0)1 46 34 51 57